Surovatamig
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
Surovatamig is a bispecific antibody of the (H-γ4_L-κ) _VH-G4 (h-CH2-CH3) type, targeting CD3D/CD3E/CD19.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog